Authors: Monforte, AD Adorni, F Meroni, L Bini, T Testa, L Chiesa, E Melzi, S Rusconi, S Sollima, S Galli, M Moroni, M

Citation: Ad. Monforte et al., Predictive role of the three-month CD4 cell count in the long-term clinical outcome of the first HAART regimen, BIOMED PHAR, 55(1), 2001, pp. 16-22

Authors: Bini, T Testa, L Chiesa, E Adorni, F Abeli, C Castelnuovo, B Melzi, S Sollima, S Bongiovanni, M Monforte, AD

Citation: T. Bini et al., Outcome of a second-line protease inhibitor-containing regimen in patientsfailing or intolerant of a first highly active antiretroviral therapy, J ACQ IMM D, 24(2), 2000, pp. 115-122

Authors: Ridolfo, AL Gervasoni, C Bini, T Galli, M

Citation: Al. Ridolfo et al., Body habitus alterations in HIV-Infected women treated with combined antiretroviral therapy, AIDS PAT CA, 14(11), 2000, pp. 595-601

Authors: Monforte, AD Testori, V Adorni, F Castelnuovo, B Bini, T Testa, L Moscatelli, G Chiesa, E Rusconi, S Abeli, C Sollima, S Musicco, M Meroni, L Galli, M Moroni, M

Citation: Ad. Monforte et al., CD4 cell counts at the third month of HAART may predict clinical failure, AIDS, 13(13), 1999, pp. 1669-1676